Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Charles River Laboratories’s reported figures.
Plus components not separately reported this period.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
FAQ
- What is Charles River Laboratories's EBIT?
- Charles River Laboratories (CRL) reported EBIT of $119.89M in Q2 2026.
- How has Charles River Laboratories's EBIT changed year-over-year?
- Charles River Laboratories's EBIT increased by 19.7% year-over-year, from $100.13M to $119.89M.
- What is the long-term trend for Charles River Laboratories's EBIT?
- Over 4 years (2021 to 2025), Charles River Laboratories's EBIT has grown at a -15.0% compound annual growth rate (CAGR), from $589.86M to $307.5M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Charles River Laboratories's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude